共 50 条
- [21] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialNATURE MEDICINE, 2023, 29 (11) : 2825 - +Galsky, Matthew D.Daneshmand, SiamakIzadmehr, SudehGonzalez-Kozlova, EdgarChan, Kevin G.Lewis, SaraAchkar, Bassam ElDorff, Tanya B.Cetnar, Jeremy PaulNeil, Brock O.D'Souza, AnishkaMamtani, RonacKyriakopoulos, ChristosJun, TomiGogerly-Moragoda, MahalyaBrody, RachelXie, HuiNie, KaiKelly, GeoffreyHorwitz, AmirKinoshita, YayoiEllis, EthanNose, YoheiIoannou, GiorgioCabal, RafaelHaines, G. KennethWang, LiMouw, Kent W.Samstein, Robert M.Mehrazin, RezaBhardwaj, NinaYu, MenggangZhao, QianqianKim-Schulze, SeungheeSebra, RobertZhu, JunGnjatic, SachaSfakianos, JohnPal, Sumanta K.
- [22] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialNature Medicine, 2023, 29 : 2825 - 2834Matthew D. GalskySiamak DaneshmandSudeh IzadmehrEdgar Gonzalez-KozlovaKevin G. ChanSara LewisBassam El AchkarTanya B. DorffJeremy Paul CetnarBrock O. NeilAnishka D’SouzaRonac MamtaniChristos KyriakopoulosTomi JunMahalya Gogerly-MoragodaRachel BrodyHui XieKai NieGeoffrey KellyAmir HorowitzYayoi KinoshitaEthan EllisYohei NoseGiorgio IoannouRafael CabalDiane M. Del ValleG. Kenneth HainesLi WangKent W. MouwRobert M. SamsteinReza MehrazinNina BhardwajMenggang YuQianqian ZhaoSeunghee Kim-SchulzeRobert SebraJun ZhuSacha GnjaticJohn SfakianosSumanta K. Pal
- [23] A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder A Retrospective ExperienceCANCER, 2008, 113 (09) : 2471 - 2477Dash, AtreyaPettus, Joseph A.Herr, Harry W.Bochner, Bernard H.Dalbagni, GuidoDonat, S. MacheleRusso, PaulBoyle, Mary G.Milowsky, Matthew I.Bajorin, Dean F.
- [24] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialEUROPEAN UROLOGY, 2024, 85 (05) : 500 - 501Moschini, MarcoNecchi, AndreaMontorsi, Francesco
- [25] Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladderINVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (02) : 168 - 174Sung, Hyun HwanKim, HanaKim, RyulKim, Chan KyoKwon, Ghee YoungPark, WonSong, WanJeong, Byong ChangPark, Se Hoon
- [26] Neoadjuvant Immunotherapy for Muscle-Invasive Bladder CancerMEDICINA-LITHUANIA, 2021, 57 (08):Peyrottes, ArthurOuzaid, IdirCalifano, GianluigiHermieu, Jean-FrancoisXylinas, Evanguelos
- [27] Neoadjuvant therapy for muscle-invasive bladder cancerEXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 603 - 614Jain, Rohit K.Sonpavde, Guru
- [28] Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancerCANCER, 2015, 121 (15) : 2586 - 2593Galsky, Matthew D.Pal, Sumanta K.Chowdhury, SimonHarshman, Lauren C.Crabb, Simon J.Wong, Yu-NingYu, Evan Y.Powles, ThomasMoshier, Erin L.Ladoire, SylvainHussain, Syed A.Agarwal, NeerajVaishampayan, Ulka N.Recine, FedericaBerthold, DominikNecchi, AndreaTheodore, ChristineMilowsky, Matthew I.Bellmunt, JoaquimRosenberg, Jonathan E.
- [29] Neoadjuvant chemotherapy (NAC) with dose-dense gemcitabine/cisplatin (DDGC) in localized muscle-invasive bladder cancer (MIBC).JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Tsironis, GeorgeZakopoulou, RoubiniKoutsoukos, KonstantinosTzanis, KimonVarkarakis, JohnPapatsoris, AthanasiosStravodimos, KostasKostouros, EfthymiosFragkoulis, CharalamposChoreftaki, TheodosiaFilippiadis, DimitriosFontara, SofiaDellis, AthanasiosNtai, SpartiZygogianni, AnnaNtoumas, KonstantinosConstantinides, Constantinos A.Korkolopoulou, PenelopeDimopoulos, Meletios A.Bamias, Aristotelis
- [30] Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgeryANNALS OF ONCOLOGY, 2023, 34 : S1210 - S1210Tong, Z.Fu, G.Zhou, F.Liu, X.Xue, X.Zhang, H.Wang, Y.Zhu, X.Gao, Y.Liu, L.Bao, X.Zheng, Y.Fang, W.Zhao, P.Jin, B.